Zobrazeno 1 - 8
of 8
pro vyhledávání: '"PER, perampanel"'
Autor:
Pierluigi Dolso, Alberto Vogrig, Giada Pauletto, Mariarosaria Valente, Annacarmen Nilo, Gian Luigi Gigli
Publikováno v:
Epilepsy & Behavior Reports, Vol 15, Iss, Pp 100393-(2021)
Epilepsy & Behavior Reports
Epilepsy & Behavior Reports
Highlights • PER showed good efficacy for the treatment of epilepsies with known etiology. • PER showed greater efficacy in patients with epilepsy due to a focal brain lesion . • PER was globally well tolerated with a good profile of safety.
Publikováno v:
Practical Laboratory Medicine, Vol 10, Iss C, Pp 15-20 (2018)
Practical Laboratory Medicine
Practical Laboratory Medicine
We present a simple and fast high-performance liquid chromatography method with fluorescence detection for the determination of the antiepileptic drug perampanel in human plasma. The chromatographic separation was performed on a Kinetex PFP (100 × 2
Publikováno v:
Epilepsy and Behavior Case Reports, Vol 11, Iss, Pp 67-69 (2019)
Epilepsy & Behavior Case Reports
Epilepsy & Behavior Case Reports
We retrospectively investigated whether perampanel (PER) could serve as an alternative for treating drug-resistant seizures in lissencephaly. We investigated the following data: age at onset of epilepsy, age at start of PER, etiology, brain MRI findi
Publikováno v:
Epilepsy and Behavior Case Reports, Vol 8, Iss C, Pp 105-107 (2017)
Epilepsy & Behavior Case Reports
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Epilepsy & Behavior Case Reports
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Perampanel is the first-in-class selective and noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist. It is authorized in the U.S. and Europe as an add-on antiepileptic drug for partial-onset seizures, and for pr
Autor:
Nilo A; Department of Medicine (DAME), University of Udine Medical School, Udine, Italy.; Clinical Neurology Unit, Department of Neurosciences, S. Maria della Misericordia University Hospital, Udine, Italy., Pauletto G; Neurology Unit, Department of Neurosciences, S. Maria della Misericordia University Hospital, Udine, Italy., Gigli GL; Department of Medicine (DAME), University of Udine Medical School, Udine, Italy.; Clinical Neurology Unit, Department of Neurosciences, S. Maria della Misericordia University Hospital, Udine, Italy.; DMIF, University of Udine, Udine, Italy., Vogrig A; Clinical Neurology Unit, Department of Neurosciences, S. Maria della Misericordia University Hospital, Udine, Italy., Dolso P; Clinical Neurology Unit, Department of Neurosciences, S. Maria della Misericordia University Hospital, Udine, Italy., Valente M; Department of Medicine (DAME), University of Udine Medical School, Udine, Italy.; Clinical Neurology Unit, Department of Neurosciences, S. Maria della Misericordia University Hospital, Udine, Italy.
Publikováno v:
Epilepsy & behavior reports [Epilepsy Behav Rep] 2020 Oct 26; Vol. 15, pp. 100393. Date of Electronic Publication: 2020 Oct 26 (Print Publication: 2021).
Autor:
Ikemoto S; Division of Neurology, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan.; Department of Pediatrics, The Jikei University School of Medicine, 3-19-18 Nishi-shinbashi, Minato-ku, Tokyo 105-8471, Japan., Hamano SI; Division of Neurology, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan.; Department for Child Health and Human Development, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan., Hirata Y; Division of Neurology, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan.; Department of Pediatrics, The Jikei University School of Medicine, 3-19-18 Nishi-shinbashi, Minato-ku, Tokyo 105-8471, Japan., Matsuura R; Division of Neurology, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan., Koichihara R; Department for Child Health and Human Development, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan.
Publikováno v:
Epilepsy & behavior case reports [Epilepsy Behav Case Rep] 2019 Jan 11; Vol. 11, pp. 67-69. Date of Electronic Publication: 2019 Jan 11 (Print Publication: 2019).
Autor:
Mohamed S; IRCCS-ISNB Institute of Neurological Sciences of Bologna, Italy., Candela C; IRCCS-ISNB Institute of Neurological Sciences of Bologna, Italy.; Department of Biomedical and Neuromotor Sciences University of Bologna, Bologna, Italy., Riva R; IRCCS-ISNB Institute of Neurological Sciences of Bologna, Italy.; Department of Biomedical and Neuromotor Sciences University of Bologna, Bologna, Italy., Contin M; IRCCS-ISNB Institute of Neurological Sciences of Bologna, Italy.; Department of Biomedical and Neuromotor Sciences University of Bologna, Bologna, Italy.
Publikováno v:
Practical laboratory medicine [Pract Lab Med] 2017 Nov 26; Vol. 10, pp. 15-20. Date of Electronic Publication: 2017 Nov 26 (Print Publication: 2018).
Autor:
Argente-Escrig H; Multidisciplinary Epilepsy Unit, Department of Neurology, Hospital Universitario y Politécnico La Fe, 106 Fernando Abril Martorell Ave, 46026, Valencia, Spain., Gómez-Ibáñez A; Multidisciplinary Epilepsy Unit, Department of Neurology, Hospital Universitario y Politécnico La Fe, 106 Fernando Abril Martorell Ave, 46026, Valencia, Spain., Villanueva V; Multidisciplinary Epilepsy Unit, Department of Neurology, Hospital Universitario y Politécnico La Fe, 106 Fernando Abril Martorell Ave, 46026, Valencia, Spain.
Publikováno v:
Epilepsy & behavior case reports [Epilepsy Behav Case Rep] 2017 Sep 27; Vol. 8, pp. 105-107. Date of Electronic Publication: 2017 Sep 27 (Print Publication: 2017).